Sinphar Pharmaceutical Co Ltd
TWSE:1734
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| TW |
|
Sinphar Pharmaceutical Co Ltd
TWSE:1734
|
5.8B TWD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
284.3B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.7B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD |
Loading...
|
Market Distribution
| Min | -22 082.4% |
| 30th Percentile | 1% |
| Median | 5.3% |
| 70th Percentile | 11.1% |
| Max | 1 580% |
Other Profitability Ratios
Sinphar Pharmaceutical Co Ltd
Glance View
Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, therapeutic drugs, medicated cosmetics, nutriment, health care foods, and cleaning liquid. The company is headquartered in Dongshan, Yilan. The company went IPO on 2000-10-17. The firm is also engaged in the sales of functional food products. The Company’s principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The firm mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Sinphar Pharmaceutical Co Ltd is 10.3%, which is below its 3-year median of 10.5%.
Over the last 3 years, Sinphar Pharmaceutical Co Ltd’s Net Margin has increased from 7.3% to 10.3%. During this period, it reached a low of 7.3% on Aug 30, 2022 and a high of 13.7% on Mar 31, 2024.
